Find a Doctor

Kristina A. Cole, MD, PhD

Attending physician

Assistant Professor, Perelman School of Medicine at the University of Pennsylvania


2007, Asco Young Investigator Award and grant

2007, David G. Nathan Award, Society for Pediatric Research and American Society for Pediatric Hematology Oncology

Original Papers


Cole KA, Huggins J, Laquaglia M, Hulderman C, Bosse K, Russel M, et al. An RNAi screen of the protein kinome identifies the cell cycle checkpoint kinase CHK1 as a therapeutic target in neuroblastoma. Proc Natl Acad Sci. 2011 Feb 22;108(8):3336-41. Cited in PubMed: PMID 21289283. Read the abstract

Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature. 2011; 469(7329):216-20. Cited in PubMed: PMID 21224317. Read the abstract


Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 2009;18;459(7249):987-91. Cited in PubMed: PMID 19536264. Read the article

Capasso M, Devoto M, Hou C, Asgharzadeh S, Glessner JT, Attiyeh EF, et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet. 2009; 41(6):718-723. Cited in PubMed: PMID 19412175. Read the article

« Back to Previous Page
  • Print
  • Share

Contact Us